David Dilworth

David Dilworth

Company: BlueRock Therapeutics

Job title: Senior Scientist


Early-Stage Potency Assay Development for Regenerative Cell Therapies 11:30 am

• Leveraging advanced technologies to increase understanding  of drug product mechanism of action towards establishing a  meaningful matrix of functional assays • Developing phase appropriate early-stage potency assays  for the characterization of pluripotent stem cell-derived  regenerative medicines  • Moving from a characterization matrix to a suitable assay for  drug product release and stability testingRead more

day: Conference Day One - Track B - AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.